rAAV2/5-PBGD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rAAV2/5-PBGD, covering 2014-12-18 to 2014-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria [Phase 1]